{"id":141857,"date":"2023-02-15T07:31:38","date_gmt":"2023-02-15T12:31:38","guid":{"rendered":"https:\/\/44.250.171.167\/?p=141857"},"modified":"2023-02-15T07:31:40","modified_gmt":"2023-02-15T12:31:40","slug":"earnings-summary-of-granules-india-limited-for-q3-fy23","status":"publish","type":"post","link":"https:\/\/alphastreet.com\/india\/earnings-summary-of-granules-india-limited-for-q3-fy23\/","title":{"rendered":"Earnings Summary Of Granules India Limited For Q3 FY23"},"content":{"rendered":"<p><a href=\"https:\/\/granulesindia.com\/\" target=\"_blank\" rel=\"noopener\">Granules India Limited<\/a> (NSE: <a href=\"https:\/\/44.250.171.167\/symbol\/granules\/\">GRANULES<\/a>) is a pharmaceutical manufacturing company based in Hyderabad, India. The company was founded in 1984 and has grown to become a leading producer of Active Pharmaceutical Ingredients (APIs), pharmaceutical formulations, and other healthcare products.<\/p>\n<p>Revenue from Operations was \u20b91,146 Cr, up 15% year on year, primarily due to higher Paracetamol API sales in the US. The revenue share from the United States increased to 49.4% in Q3 FY23, up from 43.1% the previous year. Active pharmaceutical ingredients (API), pharmaceutical formulation intermediates (PFI), and finished dosages each contribute 35.8%, 18.6%, and 45.6% of revenue from operations. The Consolidated Net Profit was \u20b9124.32 crore, up from \u20b9100.88 crore in the same quarter last year. This quarter\u2019s earnings per share was \u20b95.10.<\/p>\n<p>While operating cash flow is quite healthy at \u20b9161 Cr, free cash flow has been impacted at (\u20b932.5) Cr due to additional deployments of \u20b950 Cr in our new expansion plan with green initiatives in Kakinada and \u20b942.5 Cr for land acquisition in Vishakhapatnam. ROCE increased to 25.6% from 21.2% year on year.\u00a0<\/p>\n\n\n<div style=\"height:25px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<figure class=\"wp-block-image size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"640\" src=\"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/898c572d-b97a-4c10-acd3-c5f4d9ad88be-13-1024x640.jpg\" alt=\"\" class=\"wp-image-141860\" srcset=\"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/898c572d-b97a-4c10-acd3-c5f4d9ad88be-13-1024x640.jpg 1024w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/898c572d-b97a-4c10-acd3-c5f4d9ad88be-13-300x187.jpg 300w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/898c572d-b97a-4c10-acd3-c5f4d9ad88be-13-768x480.jpg 768w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/898c572d-b97a-4c10-acd3-c5f4d9ad88be-13-1536x960.jpg 1536w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/898c572d-b97a-4c10-acd3-c5f4d9ad88be-13-2048x1280.jpg 2048w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n","protected":false},"excerpt":{"rendered":"<p>Granules India Limited (NSE: GRANULES) is a pharmaceutical manufacturing company based in Hyderabad, India. The company was founded in 1984 and has grown to become a leading producer of Active Pharmaceutical Ingredients (APIs), pharmaceutical formulations, and other healthcare products. Revenue from Operations was \u20b91,146 Cr, up 15% year on year, primarily due to higher Paracetamol [&hellip;]<\/p>\n","protected":false},"author":1917,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[392],"tags":[1115],"class_list":["post-141857","post","type-post","status-publish","format-standard","hentry","category-earnings","tag-pharmaceuticals"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_likes_enabled":false,"jetpack-related-posts":[{"id":146247,"url":"https:\/\/alphastreet.com\/india\/earnings-summary-of-granules-india-limited-for-q4-fy23\/","url_meta":{"origin":141857,"position":0},"title":"Earnings Summary Of Granules India Limited For Q4 FY23","author":"Hardik Bhandare","date":"May 16, 2023","format":false,"excerpt":"Granules India Limited is a pharmaceutical manufacturing company based in India. The company is engaged in the production and sale of active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates (PFIs), and finished dosages (FDs). With a strong focus on quality, innovation, and customer satisfaction, Granules India has established itself as a\u2026","rel":"","context":"In &quot;Earnings&quot;","block_context":{"text":"Earnings","link":"https:\/\/alphastreet.com\/india\/category\/earnings\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/898c572d-b97a-4c10-acd3-c5f4d9ad88be-2-5.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/898c572d-b97a-4c10-acd3-c5f4d9ad88be-2-5.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/898c572d-b97a-4c10-acd3-c5f4d9ad88be-2-5.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/898c572d-b97a-4c10-acd3-c5f4d9ad88be-2-5.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/898c572d-b97a-4c10-acd3-c5f4d9ad88be-2-5.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/898c572d-b97a-4c10-acd3-c5f4d9ad88be-2-5.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":177861,"url":"https:\/\/alphastreet.com\/india\/granules-india-q3-fy26-earnings-results\/","url_meta":{"origin":141857,"position":1},"title":"Granules India Q3 FY26 Earnings Results","author":"Divyansh_Kasana","date":"January 27, 2026","format":false,"excerpt":"Executive Summary Granules India Ltd reported Q3FY26 revenues of \u20b91,388 crore, up 21.97% YoY, with consolidated net profit rising 27.12% to \u20b9150 crore. Total expenses increased 19.37% YoY to \u20b91,183 crore, reflecting efficient cost management amid strong revenue growth. Revenue & Growth Revenues grew to \u20b91,388.00 crore in Q3FY26 from\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2026\/01\/G-2.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2026\/01\/G-2.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2026\/01\/G-2.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2026\/01\/G-2.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2026\/01\/G-2.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2026\/01\/G-2.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":140534,"url":"https:\/\/alphastreet.com\/india\/granules-india-limited-q3-fy23-pat-jumped-up-to-124-crore\/","url_meta":{"origin":141857,"position":2},"title":"Granules India Limited Q3 FY23; PAT Jumped Up To 124 Crore","author":"Hardik Bhandare","date":"February 8, 2023","format":false,"excerpt":"Granules India Limited (NSE: GRANULES) reported Revenue from Operations for Q3 FY23 of \u20b91,146.12 Crore up from \u20b9996.76 Crore year on year, a growth of 15%. Consolidated Net Profit of \u20b9124.32 Crore, up 23% from \u20b9100.88 Crore in the same quarter of the previous year. The Earnings per Share is\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/25cc9501-2e87-4e7a-aacc-98b0e01348cb-scaled.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/25cc9501-2e87-4e7a-aacc-98b0e01348cb-scaled.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/25cc9501-2e87-4e7a-aacc-98b0e01348cb-scaled.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/25cc9501-2e87-4e7a-aacc-98b0e01348cb-scaled.jpg?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/25cc9501-2e87-4e7a-aacc-98b0e01348cb-scaled.jpg?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/25cc9501-2e87-4e7a-aacc-98b0e01348cb-scaled.jpg?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":142188,"url":"https:\/\/alphastreet.com\/india\/earnings-summary-of-hikal-limited-for-q3-fy23\/","url_meta":{"origin":141857,"position":3},"title":"Earnings Summary Of Hikal Limited For Q3 FY23","author":"Hardik Bhandare","date":"February 17, 2023","format":false,"excerpt":"Hikal Limited (NSE: HIKAL) is a leading Indian life sciences company with a global presence. The company specializes in developing and manufacturing intermediates, active pharmaceutical ingredients (APIs), and specialty chemicals for the pharmaceutical, agrochemical, and animal health industries. HIKAL has a strong focus on innovation and quality, which has helped\u2026","rel":"","context":"In &quot;Earnings&quot;","block_context":{"text":"Earnings","link":"https:\/\/alphastreet.com\/india\/category\/earnings\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/898c572d-b97a-4c10-acd3-c5f4d9ad88be-1-3.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/898c572d-b97a-4c10-acd3-c5f4d9ad88be-1-3.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/898c572d-b97a-4c10-acd3-c5f4d9ad88be-1-3.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/898c572d-b97a-4c10-acd3-c5f4d9ad88be-1-3.jpg?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/898c572d-b97a-4c10-acd3-c5f4d9ad88be-1-3.jpg?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/898c572d-b97a-4c10-acd3-c5f4d9ad88be-1-3.jpg?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":172455,"url":"https:\/\/alphastreet.com\/india\/granules-india-q2-fy26-earnings-results\/","url_meta":{"origin":141857,"position":4},"title":"Granules India Q2 FY26 Earnings Results","author":"Divyansh_Kasana","date":"November 18, 2025","format":false,"excerpt":"Granules India Ltd and its subsidiaries, specializing in Active Pharma Ingredients (APIs), Pharmaceutical Formulation Intermediates (PFIs), and Finished Dosages, posted impressive financial results for Q2FY26. Financial Highlights: Revenues increased 34.13% year-on-year to \u20b91,297 crore from \u20b9967 crore. Total expenses rose 33.02% to \u20b91,120 crore from \u20b9842 crore. Consolidated net profit\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"Q2 FY26","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/11\/G-6.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/11\/G-6.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/11\/G-6.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/11\/G-6.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/11\/G-6.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/11\/G-6.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":142932,"url":"https:\/\/alphastreet.com\/india\/earnings-summary-of-ipca-laboratories-limited-for-q3-fy23\/","url_meta":{"origin":141857,"position":5},"title":"Earnings Summary Of IPCA Laboratories Limited For Q3 FY23","author":"Hardik Bhandare","date":"February 27, 2023","format":false,"excerpt":"Ipca Laboratories (NSE: IPCALAB) is a leading pharmaceutical company in India that produces and markets a broad range of prescription and non-prescription drugs, APIs (Active Pharmaceutical Ingredients), and intermediates. The company was founded in 1949 and is headquartered in Mumbai, India. It has a global presence with operations in over\u2026","rel":"","context":"In &quot;Earnings&quot;","block_context":{"text":"Earnings","link":"https:\/\/alphastreet.com\/india\/category\/earnings\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]}],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/141857","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/users\/1917"}],"replies":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/comments?post=141857"}],"version-history":[{"count":0,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/141857\/revisions"}],"wp:attachment":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media?parent=141857"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/categories?post=141857"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/tags?post=141857"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}